Triple

T22404557
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EU) 2019/6 E553847 entity
Predicate officialTitle P3342 FINISHED
Object Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC | Statement: [Regulation (EU) 2019/6, officialTitle, Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC
Context triple: [Regulation (EU) 2019/6, officialTitle, Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC]
  • A. Veterinary Medicines Regulations
    The Veterinary Medicines Regulations are a set of UK laws that govern the authorization, manufacture, distribution, and use of veterinary medicinal products to ensure animal health, public safety, and environmental protection.
  • B. Regulation (EC) No 1902/2006 amending Regulation (EC) No 1901/2006
    Regulation (EC) No 1902/2006 is a European Union legislative act that revises and supplements the original Paediatric Regulation (EC) No 1901/2006, refining the legal framework for the development and authorisation of medicines for children.
  • C. Regulation (EU) No 648/2012
    Regulation (EU) No 648/2012, known as the European Market Infrastructure Regulation (EMIR), is an EU law that increases transparency and reduces systemic risk in over-the-counter derivatives markets through requirements such as central clearing, reporting, and risk mitigation.
  • D. Regulation (EU) No 603/2013
    Regulation (EU) No 603/2013 is an EU law that governs the operation and use of the Eurodac fingerprint database for identifying asylum seekers and certain irregular migrants.
  • E. Regulation (EC) No 1901/2006
    Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC
Target entity description: Regulation (EU) 2019/6 is a comprehensive EU law that modernizes and harmonizes the rules governing the authorization, manufacture, distribution, and use of veterinary medicinal products across Member States.
  • A. Veterinary Medicines Regulations
    The Veterinary Medicines Regulations are a set of UK laws that govern the authorization, manufacture, distribution, and use of veterinary medicinal products to ensure animal health, public safety, and environmental protection.
  • B. Regulation (EC) No 1902/2006 amending Regulation (EC) No 1901/2006
    Regulation (EC) No 1902/2006 is a European Union legislative act that revises and supplements the original Paediatric Regulation (EC) No 1901/2006, refining the legal framework for the development and authorisation of medicines for children.
  • C. Regulation (EU) No 648/2012
    Regulation (EU) No 648/2012, known as the European Market Infrastructure Regulation (EMIR), is an EU law that increases transparency and reduces systemic risk in over-the-counter derivatives markets through requirements such as central clearing, reporting, and risk mitigation.
  • D. Regulation (EU) No 603/2013
    Regulation (EU) No 603/2013 is an EU law that governs the operation and use of the Eurodac fingerprint database for identifying asylum seekers and certain irregular migrants.
  • E. Regulation (EC) No 1901/2006
    Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e4da7048190b4387d422a9a0de5 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f158b6762c8190991fc14c5ca8e609 completed April 29, 2026, 1:02 a.m.
Created at: April 16, 2026, 8:46 p.m.